Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
MacroGenics Revenue Surges 155% to $150M in 2024 Financial Results ...
MacroGenics gets $100 million milestone from Incyte | Biotechnology ...
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 ...
Validation in Clinical Data Management | MacroGenics Case Study
The headquarters of the genetics firm MacroGenics Stock Photo - Alamy
Macrogenics 2026 Company Profile: Stock Performance & Earnings | PitchBook
MacroGenics Inc - AnnualReports.com
Macrogenics hi-res stock photography and images - Alamy
KONSKIE, POLAND - July 18, 2022: MacroGenics biopharmaceutical company ...
How MacroGenics accelerated antibody-based cancer research with ...
MacroGenics - Crunchbase Company Profile & Funding
A logo sign outside of the headquarters of MacroGenics in Rockville ...
MacroGenics Acquires Raven Biotechnologies
MacroGenics (MGNX) Investor Presentation - Slideshow (NASDAQ:MGNX ...
What is Competitive Landscape of MacroGenics Company ...
How Does MacroGenics Company Work? – PortersFiveForce.com
MacroGenics Announces $15 Million Milestone | citybiz
MacroGenics Announces Sale of TZIELD Royalty Interest for up to $200M ...
MacroGenics 2020 Investor Materials
Macrogenics Inc (MGNX) Reports Strong Financial Position and ...
Macrogenics Logo Single Use Helps Give Biotechs Flexibility,
MacroGenics & Takeda Develop Bi-Specific Antibodies For Autoimmune ...
MacroGenics earned FDA approval for breast cancer treatment Margenza ...
MacroGenics and I-Mab Announce Exclusive Collaboration and License ...
CDMO Capabilities – MacroGenics
MacroGenics seeks FDA approval for breast cancer treatment - Washington ...
Logotipo De Macrogenics Final Trades: Johnson & Johnson, Charles
MacroGenics Faces Investor Scrutiny After Clinical Trial Setbacks ...
Platforms – MacroGenics
MacroGenics - 2026 Company Profile, Funding, Competitors & Financials ...
MacroGenics Draws Attention for Its Outstanding Progress in Prostate ...
What is Brief History of MacroGenics Company? – PortersFiveForce.com
GSK's $950M PAH Bet, FDA "Bespoke" Pathway, MacroGenics Clinical Hold ...
MacroGenics Q1 2025 Earnings Release: Navigating Strategic Shifts in a ...
MacroGenics to Sell GMP Manufacturing Operations to Bora ...
MacroGenics Aktie: FDA-Sperre aufgehoben
What are the Porter's Five Forces of MacroGenics – MatrixBCG.com
MacroGenics | The Org
MacroGenics FDA lifts hold on Phase 2 LINNET study | MGNX Stock News
Who Owns MacroGenics Company? – PortersFiveForce.com
What is Brief History of MacroGenics Company? – SWOTTemplate.com
MacroGenics (MGNX) price target increased by 50.00% to 6.12
Bora Pharmaceuticals Acquires MacroGenics Manufacturing Operations in ...
MacroGenics Investors Face a Waiting Game as Key Catalysts Shift to ...
MacroGenics BCG Matrix Analysis – SWOTTemplate.com
MacroGenics Aktie: Finanzielle Atempause
MacroGenics margetuximab gets FDA orphan drug designation for gastric ...
Gilead pledges $1.76bn to MacroGenics for bispecific cancer antibody ...
What is Growth Strategy and Future Prospects of MacroGenics Company ...
J&J commits $740M for its second cancer R&D pact with MacroGenics ...
MacroGenics has restructured and inked a major partnership. Here's what ...
What are Mission Vision & Core Values of MacroGenics Company ...
Gilead pledges $1.76bn to MacroGenics for bispecific cancer antibody
Macrogenics Inc (MGNX) Q3 2024 Earnings Call Highlights: Revenue Surge ...
Rockville biotech firm MacroGenics files for IPO
MacroGenics and TerSera: A Strategic Acquisition with Significant Risks
MacroGenics Announces FDA Approval of MARGENZA™ for Patients with ...
MacroGenics sells breast cancer treatment Margenza to TerSera ...
MacroGenics Stock | US5560991094 | A1W6ND
MacroGenics Inc(MGNX) cena, wiadomości i prognozy
MacroGenics dosing in prostate cancer trial | LucidQuest posted on the ...
Portfolio | Sanofi Ventures
MacroGenics, AbbVie stop development of partnered ADC – Midwest Region ...
5 Biotech Companies in Maryland Making History With Gene Therapies
«Макродженикс» (MacroGenics) | МОСМЕДПРЕПАРАТЫ
MacroGenics: королева биспецифических моноклональных антител ...
MacroGenics, Inc. 2023 Q1 - Results - Earnings Call Presentation ...
MacroGenics, Janssen Biotech ink deal worth up to $332M - Washington ...
17.6亿美元：吉利德引进Macrogenics三款双抗新药 Armstrong 2022年10月17日， 吉利 德宣布与 ...
TerSera acquires global rights to MacroGenics' MARGENZA
MacroGenics, Inc. posted on LinkedIn
Associate Scientist I Role at MacroGenics, Inc. - Apply Now ...
#macrogenics #newhires | MacroGenics, Inc.
Incyte to Develop MacroGenics' Cancer Immunotherapy MGA012 in Up-to ...
Converting an existing building into a research and CGMP manufacturing ...
MacroGenics, Inc. on LinkedIn: #macrogenics #clinicaldevelopment #careers
#biotech | MacroGenics, Inc.
macrogenics20logo_jpgormat.jpg
Theratechnologies Inc Peers & Key Competitors - GlobalData
Bioprocessing Summit Europe Attendees List 2026 - BizProspex
Clinical Management Systems | MasterControl
MacroGenics, Inc. - Rivervest
MacroGenics靶向B7-H3 ADC藥5名受試者死亡、過半患者出現3級不良事件-環球生技月刊
MacroGenics: Business Model Canvas – MatrixBCG.com
MacroGenics, AbbVie stop development of partnered ADC - San Francisco ...
Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab ...
Find a Prostate Cancer Support Group | ZERO Prostate Cancer
%20(Large).svg)
